Systemic inflammation, coagulopathy, and acute renal insufficiency following endovascular thoracoabdominal aortic aneurysm repair

Catherine K Chang, Timothy A M Chuter, Claus U Niemann, Michael G Shlipak, Mitchell J Cohen, Linda M Reilly, Jade S Hiramoto, Catherine K Chang, Timothy A M Chuter, Claus U Niemann, Michael G Shlipak, Mitchell J Cohen, Linda M Reilly, Jade S Hiramoto

Abstract

Objective: To characterize the inflammatory and coagulopathic response after endovascular thoracoabdominal aortic aneurysm (TAAA) repair and to evaluate the effect of the response on postoperative renal function.

Methods: From July 2005 to June 2008, 42 patients underwent elective endovascular repair of a TAAA using custom designed multi-branched stent-grafts at a single academic institution. Four patients were excluded from the analysis. White blood cell count (WBC), platelet count, prothrombin time (PT), and creatinine were measured in all patients. In the last nine patients, interleukin-6 (IL-6), protein C, Factor V, d-dimers, cystatin C, and neutrophil gelatinase-associated lipocalin (NGAL) levels were also measured. Change in lab values were expressed as a percentage of baseline values.

Results: The 30-day mortality rate was 5% (2/38). All patients (n = 38) had a higher WBC (mean +/- SD: 139 +/- 80%, P < .0001), lower platelet count (56 +/- 15%, P < .0001), and higher PT (median: 17%, Interquartile range (IQR) 12%-22%, P < .0001) after stent-graft insertion. Twelve of 38 patients (32%) developed postoperative acute renal insufficiency (>50% rise in creatinine). Patients with renal insufficiency had significantly larger changes in WBC (178 +/- 100% vs 121 +/- 64%, P = .04) and platelet count (64 +/- 17% vs 52 +/- 12%, P = .02) compared with those without renal insufficiency. All patients (n = 9) had significant increases in NGAL (182 +/- 115%, P = .008) after stent-graft insertion. Six of nine patients (67%) had increased cystatin C (35 +/- 43%, P = .04) after stent-graft insertion, with a greater rise in those with postoperative renal insufficiency (87 +/- 32% vs 8 +/- 13%, P = .02). IL-6 levels were markedly increased in all patients (n = 9) after repair (9840 +/- 6160%, P = .008). Protein C (35 +/- 10%, P = .008) and Factor V levels (28 +/- 20%, P = .008) were uniformly decreased, while d-dimers were elevated after repair in all patients (310 +/- 213%, P = .008).

Conclusions: Leukocytosis and thrombocytopenia were uniform following endovascular TAAA repair, and the severity of the response correlated with post-operative renal dysfunction. Elevation of a sensitive marker of renal injury (NGAL) suggests that renal injury may occur in all patients after stent-graft insertion.

Trial registration: ClinicalTrials.gov NCT00483249.

Figures

Figure 1
Figure 1
Computed tomographic angiography with 3-dimensional reconstruction after multi-branched endovascular TAAA repair.
Figure 2
Figure 2
Comparison of changes in WBC and platelet count after endovascular TAAA repair between patients with and without post-operative renal insufficiency
Figure 3a
Figure 3a
Uni-variate linear regression of post-operative change in serum creatinine using change in WBC as the predictor variable.
Figure 3b
Figure 3b
Uni-variate linear regression of post-operative change in serum creatinine using change in platelet count as the predictor variable.
Figure 4a
Figure 4a
Rise in NGAL levels over time following endovascular TAAA repair (n=9).
Figure 4b
Figure 4b
Rise in cystatin C levels over time following endovascular TAAA repair (n=9).
Figure 5
Figure 5
Rise in IL6 levels over time following endovascular TAAA repair (n=9).
Figure 6a
Figure 6a
Fall in factor V and protein C levels over time following endovascular TAAA repair (n=9).
Figure 6b
Figure 6b

Source: PubMed

3
Suscribir